Astragaloside IV ameliorated neuroinflammation and improved neurological functions in mice exposed to traumatic brain injury by modulating the PERK-eIF2α-ATF4 signaling pathway
Restricted accessResearch articleFirst published online October, 2024
Astragaloside IV ameliorated neuroinflammation and improved neurological functions in mice exposed to traumatic brain injury by modulating the PERK-eIF2α-ATF4 signaling pathway
Increasing evidence suggests that endoplasmic reticulum stress (ER stress) and neuroinflammation are involved in the complex pathological process of traumatic brain injury (TBI). However, the pathological mechanisms of their interactions in TBI remain incompletely elucidated. Therefore, investigating and ameliorating neuroinflammation and ER stress post-TBI may represent effective strategies for treating secondary brain injury. Astragaloside IV (AS-IV) has been reported as a potential neuroprotective and anti-inflammatory agent in neurological diseases. This study utilized a mouse TBI model to investigate the pathological mechanisms and crosstalk of ER stress, neuroinflammation, and microglial cell morphology in TBI, as well as the mechanisms and potential of AS-IV in improving TBI. The research revealed that post-TBI, inflammatory factors IL-6, IL-1β, and TNF-α increased, microglial cells were activated, and the specific inhibitor of PERK phosphorylation, GSK2656157, intervened to alleviate neuroinflammation and inhibit microglial cell activation. Post-TBI, levels of ER stress-related proteins (p-PERK, p-eIF2a, ATF4, ATF6, and p-IRE1a) increased. Following AS-IV treatment, neurological dysfunction in TBI mice improved. Levels of p-PERK, p-eIF2a, and ATF4 decreased, along with reductions in inflammatory factors IL-6, IL-1β, and TNF-α. Changes in microglial/macrophage M1/M2 polarization were observed. Additionally, the PERK activator CCT020312 intervention eliminated the impact of AS-IV on post-TBI inflammation and ER stress-related proteins p-PERK, p-eIF2a, and ATF4. These results indicate that AS-IV alleviates neuroinflammation and brain damage post-TBI through the PERK pathway, offering new directions and theoretical insights for TBI treatment.
CapizziAWooJVerduzco-GutierrezM. Traumatic brain injury: an overview of epidemiology, pathophysiology, and medical management. Med Clin North Am2020; 104(2): 213–238.
2.
JiangJYGaoGYFengJF, et al. Traumatic brain injury in China. Lancet Neurol2019; 18(3): 286–295.
3.
HubbardWBSpryMLGoochJL, et al. Clinically relevant mitochondrial-targeted therapy improves chronic outcomes after traumatic brain injury. Brain2021; 144(12): 3788–3807.
4.
BaoZLiuYChenB, et al. Prokineticin-2 prevents neuronal cell deaths in a model of traumatic brain injury. Nat Commun2021; 12(1): 4220.
5.
NgSYLeeAYW. Traumatic brain injuries: pathophysiology and potential therapeutic targets. Front Cell Neurosci2019; 13: 528.
6.
SunGWDingTYWangM, et al. Honokiol reduces mitochondrial dysfunction and inhibits apoptosis of nerve cells in rats with traumatic brain injury by activating the mitochondrial unfolded protein response. J Mol Neurosci2022; 72(12): 2464–2472.
7.
van ErpIAMMichailidouIvan EssenTA, et al. Tackling neuroinflammation after traumatic brain injury: complement inhibition as a therapy for secondary injury. Neurotherapeutics2023; 20(1): 284-303.
8.
ZhaoPWeiYSunG, et al. Fetuin-A alleviates neuroinflammation against traumatic brain injury-induced microglial necroptosis by regulating Nrf-2/HO-1 pathway. J Neuroinflammation2022; 19(1): 269.
9.
LindholmDWootzHKorhonenL. ER stress and neurodegenerative diseases. Cell Death Differ2006; 13(3): 385–392.
10.
SaitoAImaizumiK. Unfolded protein response-dependent communication and contact among endoplasmic reticulum, mitochondria, and plasmamembrane. Int J Mol Sci2018;19(10): 3215.
11.
ChenXMiLGuG, et al. Dysfunctional endoplasmic reticulum-mitochondrion coupling is associated with endoplasmic reticulum stress-induced apoptosis and neurological deficits in a rodent model of severe head injury. J Neurotrauma2022; 39(7–8): 560–576.
12.
HollienJ. Evolution of the unfolded protein response. Biochim Biophys Acta2013; 1833(11): 2458–2463.
13.
HetzC. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol2012; 13(2): 89–102.
14.
ChenYBrandizziF. IRE1: ER stress sensor and cell fate executor. Trends Cell Biol2013; 23(11): 547–555.
15.
PeharMJonasMCHareTM, et al. SLC33A1/AT-1 protein regulates the induction of autophagy downstream of IRE1/XBP1 pathway. J Biol Chem2012; 287(35): 29921–29930.
16.
TianPGJiangZXLiJH, et al. Spliced XBP1 promotes macrophage survival and autophagy by interacting with Beclin-1. Biochem Biophys Res Commun2015; 463(4): 518–523.
17.
DeeganSKorygaIGlynnSA, et al. A close connection between the PERK and IRE arms of the UPR and the transcriptional regulation of autophagy. Biochem Biophys Res Commun2015; 456(1): 305–311.
18.
RonDWalterP. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol2007; 8(7): 519–529.
19.
JiangHYWekRC. Phosphorylation of the alpha-subunit of the eukaryotic initiation factor-2 (eIF2alpha) reduces protein synthesis and enhances apoptosis in response to proteasome inhibition. J Biol Chem2005; 280(14): 14189–14202.
20.
HanJBackSHHurJ, et al. ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat Cell Biol2013; 15(5): 481–490.
21.
HardingHPZhangYZengH, et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell2003; 11(3): 619–633.
22.
TanHPGuoQHuaG, et al. Inhibition of endoplasmic reticulum stress alleviates secondary injury after traumatic brain injury. Neural Regen Res2018; 13(5): 827–836.
23.
SenTGuptaRKaiserH, et al. Activation of PERK elicits memory impairment through inactivation of CREB and downregulation of PSD95 after traumatic brain injury. J Neurosci2017; 37(24): 5900–5911.
24.
MengCZhangJDangB, et al. PERK pathway activation promotes intracerebral hemorrhage induced secondary brain injury by inducing neuronal apoptosis both in vivo and in vitro. Front Neurosci2018; 12: 111.
25.
LiuCFuQMuR, et al. Dexmedetomidine alleviates cerebral ischemia-reperfusion injury by inhibiting endoplasmic reticulum stress dependent apoptosis through the PERK-CHOP-Caspase-11 pathway. Brain Res2018; 1701: 246–254.
26.
TurtzoLCLescherJJanesL, et al. Macrophagic and microglial responses after focal traumatic brain injury in the female rat. J Neuroinflammation2014; 11: 82.
27.
KumarAAlvarez-CrodaDMStoicaBA, et al. Microglial/macrophage polarization dynamics following traumatic brain injury. J Neurotrauma2016; 33(19): 1732–1750.
28.
WuHZhengJXuS, et al. Mer regulates microglial/macrophage M1/M2 polarization and alleviates neuroinflammation following traumatic brain injury. J Neuroinflammation2021; 18(1): 2.
29.
XuXGaoWChengS, et al. Anti-inflammatory and immunomodulatory mechanisms of atorvastatin in a murine model of traumatic brain injury. J Neuroinflammation2017; 14(1): 167.
30.
SenTSahaPGuptaR, et al. Aberrant ER stress induced neuronal-IFNβ elicits white matter injury due to microglial activation and T-cell infiltration after TBI. J Neurosci2020; 40(2): 424–446.
31.
LiHZhangYMinJ, et al. Astragaloside IV attenuates orbital inflammation in Graves’ orbitopathy through suppression of autophagy. Inflamm Res2018; 67(2): 117–127.
32.
KongXLLyuQZhangYQ, et al. Effect of astragaloside IV and salvianolic acid B on antioxidant stress and vascular endothelial protection in the treatment of atherosclerosis based on metabonomics. Chin J Nat Med2022; 20(8): 601–613.
33.
LiLHouXXuR, et al. Research review on the pharmacological effects of astragaloside IV. Fundam Clin Pharmacol2017; 31(1): 17–36.
34.
ChenFYangDChengXY, et al. Astragaloside IV ameliorates cognitive impairment and neuroinflammation in an oligomeric Aβ induced alzheimer’s disease mouse model via inhibition of microglial activation and NADPH oxidase expression. Biol Pharm Bull2021; 44(11): 1688–1696.
35.
DuSJZhangYZhaoYM, et al. Astragaloside IV attenuates cerebral ischemia-reperfusion injury in rats through the inhibition of calcium-sensing receptor-mediated apoptosis. Int J Mol Med2021; 47(1): 302–314.
36.
ZhangYZhangYJinXF, et al. The role of Astragaloside IV against cerebral Ischemia/Reperfusion injury: Suppression of apoptosis via promotion of P62-LC3-autophagy. Molecules2019; 24(9): 1838.
37.
XiaMLXieXHDingJH, et al. Astragaloside IV inhibits astrocyte senescence: implication in Parkinson’s disease. J Neuroinflammation2020; 17(1): 105.
38.
YangCMoYXuE, et al. Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson’s disease mouse model. Int Immunopharmacol2019; 75: 105651.
39.
ChanWSDurairajanSSLuJH, et al. Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture. Neurochem Int2009; 55(6): 414–22.
40.
LiuHSShiHLHuangF, et al. Astragaloside IV inhibits microglia activation via glucocorticoid receptor mediated signaling pathway. Sci Rep2016; 6: 19137.
41.
LiMLiHFangF, et al. Astragaloside IV attenuates cognitive impairments induced by transient cerebral ischemia and reperfusion in mice via anti-inflammatory mechanisms. Neurosci Lett2017; 639: 114–119.
42.
LiMQuYZZhaoZW, et al. Astragaloside IV protects against focal cerebral ischemia/reperfusion injury correlating to suppression of neutrophils adhesion-related molecules. Neurochem Int2012; 60(5): 458–465.
43.
HeYDuMGaoY, et al. Astragaloside IV attenuates experimental autoimmune encephalomyelitis of mice by counteracting oxidative stress at multiple levels. PLoS One2013; 8(10): e76495.
44.
HouBLiuRWuY, et al. Astragaloside IV reduces cerebral ischemia/reperfusion-induced blood-brain barrier permeability in rats by inhibiting ER stress-mediated apoptosis. Evid Based Complement Alternat Med2020; 2020: 9087873.
45.
LiLGanHJinH, et al. Astragaloside IV promotes microglia/macrophages M2 polarization and enhances neurogenesis and angiogenesis through PPARγ pathway after cerebral ischemia/reperfusion injury in rats. Int Immunopharmacol2021; 92: 107335.
46.
ChenYGuiDChenJ, et al. Down-regulation of PERK-ATF4-CHOP pathway by Astragaloside IV is associated with the inhibition of endoplasmic reticulum stress-induced podocyte apoptosis in diabetic rats. Cell Physiol Biochem2014; 33(6): 1975–1987.
47.
ShaoAGuoSTuS, et al. Astragaloside IV alleviates early brain injury following experimental subarachnoid hemorrhage in rats. Int J Med Sci2014;11(10):1073–1081.
48.
SunGZhaoZLangJ, et al. Nrf2 loss of function exacerbates endoplasmic reticulum stress-induced apoptosis in TBI mice. Neurosci Lett2022; 770: 136400.
49.
GanzJShachamTKramerM, et al. A novel specific PERK activator reduces toxicity and extends survival in Huntington’s disease models. Sci Rep2020; 10(1): 6875.
50.
WuHShaoAZhaoM, et al. Melatonin attenuates neuronal apoptosis through up-regulation of K(+) -Cl(-) cotransporter KCC2 expression following traumatic brain injury in rats. J Pineal Res2016; 61(2): 241–250.
51.
ZhengJSunZLiangF, et al. AdipoRon attenuates neuroinflammation after intracerebral hemorrhage through AdipoR1-AMPK pathway. Neuroscience2019; 412: 116–130.
52.
JacquensANeedhamEJZanierER, et al. Neuro-inflammation modulation and post-traumatic brain injury lesions: from bench to bed-side. Int J Mol Sci2022; 23(19)911193
53.
WangZFGaoCChenW, et al. Salubrinal offers neuroprotection through suppressing endoplasmic reticulum stress, autophagy and apoptosis in a mouse traumatic brain injury model. Neurobiol Learn Mem2019; 161: 12–25.
54.
ShiKZhangJDongJF, et al. Dissemination of brain inflammation in traumatic brain injury. Cell Mol Immunol2019; 16(6): 523–530.
55.
SimonDWMcGeachyMJBayırH, et al. The far-reaching scope of neuroinflammation after traumatic brain injury. Nat Rev Neurol2017;13(3):171-191.
56.
KrämerTJHackNBrühlTJ, et al. Depletion of regulatory T cells increases T cell brain infiltration, reactive astrogliosis, and interferon-γ gene expression in acute experimental traumatic brain injury. J Neuroinflammation2019; 16(1): 163.
57.
WangYChenYZhouQ, et al. Mild endoplasmic reticulum stress protects against lipopolysaccharide-induced astrocytic activation and blood-brain barrier hyperpermeability. Front Cell Neurosci2018; 12: 222.
58.
ZhangKKaufmanRJ. From endoplasmic-reticulum stress to the inflammatory response. Nature2008; 454(7203): 455–462.
59.
ZhangJZhangPMengC, et al. The PERK pathway plays a neuroprotective role during the early phase of secondary brain injury induced by experimental intracerebral hemorrhage. Acta Neurochir Suppl2020; 127: 105–119.
60.
MearesGPLiuYRajbhandariR, et al. PERK-dependent activation of JAK1 and STAT3 contributes to endoplasmic reticulum stress-induced inflammation. Mol Cell Biol2014; 34(20): 3911–3925.
61.
ZhuYYuJGongJ, et al. PTP1B inhibitor alleviates deleterious microglial activation and neuronal injury after ischemic stroke by modulating the ER stress-autophagy axis via PERK signaling in microglia. Aging (Albany NY)2021;13(3): 3405–3427.
62.
XuXFShiMMLuoMY, et al. Targeting PERK mediated endoplasmic reticulum stress attenuates neuroinflammation and alleviates lipopolysaccharide-induced depressive-like behavior in male mice. Int Immunopharmacol2022; 111: 109092.
63.
LiLLuoQShangB, et al. Selective activation of cannabinoid receptor-2 reduces white matter injury via PERK signaling in a rat model of traumatic brain injury. Exp Neurol2022; 347: 113899.
64.
YuJMuBGuoM, et al. Astragaloside IV inhibits experimental autoimmune encephalomyelitis by modulating the polarization of both microglia/macrophages and astrocytes. Folia Neuropathol2023; 61(3): 273–290.
65.
CowanMPetriWAJr.Microglia: Immune regulators of neurodevelopment. Front Immunol2018; 9: 2576.
66.
StratouliasVVeneroJLTremblayM, et al. Microglial subtypes: diversity within the microglial community. Embo J2019; 38(17): e101997.
67.
RosiS. A polarizing view on posttraumatic brain injury inflammatory response. Brain Circ2016; 2(3): 126–128.
68.
XuHWangZLiJ, et al. The polarization states of microglia in TBI: a new paradigm for pharmacological intervention. Neural Plast2017; 2017: 5405104.
69.
ZhuJCaoDGuoC, et al. Berberine facilitates angiogenesis against ischemic stroke through modulating microglial polarization via AMPK signaling. Cell Mol Neurobiol2019; 39(6): 751–768.
70.
KobayashiKImagamaSOhgomoriT, et al. Minocycline selectively inhibits M1 polarization of microglia. Cell Death Dis2013; 4(3): e525.
71.
YuJGuoMLiY, et al. Astragaloside IV protects neurons from microglia-mediated cell damage through promoting microglia polarization. Folia Neuropathol2019; 57(2): 170–181.
72.
LinJPanXHuangC, et al. Dual regulation of microglia and neurons by Astragaloside IV-mediated mTORC1 suppression promotes functional recovery after acute spinal cord injury. J Cell Mol Med2020; 24(1): 671–685.
